Internal Medicine Doctors in Bayamon, PR Accepting Medicare

206 Internal Medicine doctors found. Showing 201 - 206

Yelitza Ruiz, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Paseo San Pablo, Edif Arturo Cadilla Suite 510, Bayamon, PR 00961 Phone: 787-780-2830    Fax: 787-786-8281

Samuel Padilla Machuca, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1845 Bayamon Medical Plaza, Ste 509, Bayamon, PR 00960 Phone: 787-786-9200    Fax: 787-786-9700

Luis Benjamin Gonzalez-ingles, MD Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: J16 Calle 2 Villa Rica, Edificio Medico Hermanas Davila Suite 108, Bayamon, PR 00959 Phone: 787-288-2255    Fax: 787-288-2255

Yolanda Lopez-lopez, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 66 Calle Santa Cruz, Suite 307 Instituto San Pablo, Bayamon, PR 00961 Phone: 787-798-8486    Fax: 787-740-7170

Dr. Ramon A Bassa Ramirez Jr., M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: Calle Sta Cruz Edif 64, Galeria Medica Suite 103, Bayamon, PR 00960 Phone: 787-785-8540    Fax: 787-785-8540

Dr. Lourdes M Tirado Marrero, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 132 Villas De La Fuente, Bayamon, PR 00959 Phone: 787-366-5663

News Archive

Group Health Research Institute conducts first randomized trial to tackle vaccine hesitancy

Group Health Research Institute conducted the first randomized trial to test an intervention aimed at improving hesitancy about early childhood vaccines by working directly with doctors. Vax Northwest, a Washington state public-private partnership, developed the intervention.

58% of Americans believe that H1N1 flu is a serious health hazard: Survey

A majority (58%) of Americans believe that the H1N1 flu is a serious health hazard, according to a new survey released today by Silverlink Communications, Inc. This represents a marked increase as compared to May 2009, when 47% of Americans held this same perception of H1N1. While most Americans believe H1N1 is a serious health hazard, less than one-third (31%) of Americans plan on getting the H1N1 flu vaccine this year, with safety and efficacy of the vaccine cited as primary barriers for not getting the vaccine. Of particular concern, less than 27% of 18 to 24 year olds, a high risk group, plan on getting the H1N1 vaccine.

MicroStockProfit.com releases investment report on Discovery Laboratories

MicroStockProfit.com announces an investment report featuring Discovery Laboratories Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

Ocular drug delivery: DSM awarded membership in PANOPTES EU Funded Consortium

DSM, a global leader in biomedical materials sciences, today announced that it is contributing proprietary knowledge in the preparation of tailored amino acid-based polymers and offering use of processing facilities that will produce an innovative step change in the sustained delivery of drug molecules. The PANOPTES consortium's goal is to research and develop novel drug delivery technology for the posterior eye segment. This partnership further validates the innovative properties of DSM's polyesteramide (PEA) biomaterials as a superior drug delivery technology.

Read more Medical News

› Verified 3 days ago

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11(current)